Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated May 16, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 24.6B USD
- Positions
- 90
- Share of the ten largest
- 40.2%
The ten largest positions Q1 2022
- T-Mobile US 7.0%▲ +2.1%
- Amazon 5.6%▲ +52.0%
- GE Aerospace 4.8%▼ −29.0%
- Microsoft 4.2%▲ +13.2%
- Brookfield Asset Mgmt Inc 3.7%▼ −7.4%
- Parker Hannifin 3.6%▲ +3.5%
- Fortive 3.0%▲ +41.8%
- Api Group Corp 2.9%▲ +0.4%
- Chubb Limited 2.8%▼ −13.3%
- Comcast 2.7%▼ −0.9%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TMUS T-Mobile US | 7.0% | 13,418,175 | 1.7B USD | +2.1% increased | Q1 2020 9 quarters |
| AMZN Amazon | 5.6% | 422,853 | 1.4B USD | +52.0% increased | Q2 2015 28 quarters |
| GE GE Aerospace | 4.8% | 12,808,478 | 1.2B USD | −29.0% reduced | Q4 2020 6 quarters |
| MSFT Microsoft | 4.2% | 3,319,116 | 1.0B USD | +13.2% increased | Q2 2016 24 quarters |
| Brookfield Asset Mgmt Inc | 3.7% | 16,304,989 | 922.4M USD | −7.4% reduced | Q2 2021 4 quarters |
| PH Parker Hannifin | 3.6% | 3,165,334 | 898.2M USD | +3.5% increased | Q2 2020 8 quarters |
| FTV Fortive | 3.0% | 12,033,157 | 733.2M USD | +41.8% increased | Q3 2019 11 quarters |
| Api Group Corp | 2.9% | 33,463,200 | 703.7M USD | +0.4% increased | Q2 2020 8 quarters |
| CB Chubb Limited | 2.8% | 3,201,215 | 684.7M USD | −13.3% reduced | Q1 2020 9 quarters |
| CMCSA Comcast | 2.7% | 14,078,668 | 659.2M USD | −0.9% reduced | Q3 2021 3 quarters |
| CNC Centene Corporation | 2.7% | 7,806,040 | 657.2M USD | −9.4% reduced | Q2 2018 16 quarters |
| MA Mastercard | 2.6% | 1,793,488 | 641.0M USD | new | Q1 2022 1 quarter |
| V Visa Inc. | 2.3% | 2,597,820 | 576.1M USD | −34.6% reduced | Q3 2016 23 quarters |
| BSX Boston Scientific | 2.3% | 12,839,142 | 568.6M USD | −32.3% reduced | Q3 2018 15 quarters |
| WDAY Workday, Inc. | 2.2% | 2,253,470 | 539.6M USD | +28.7% increased | Q4 2021 2 quarters |
| AON Aon plc | 2.1% | 1,593,080 | 518.8M USD | +5.5% increased | Q4 2021 2 quarters |
| IFF International Flavors & Fragrances | 2.0% | 3,797,230 | 498.7M USD | +643.1% increased | Q4 2021 2 quarters |
| Roivant Sciences Ltd | 1.8% | 88,238,700 | 435.9M USD | unchanged | Q4 2021 2 quarters |
| Hdfc Bank Ltd | 1.8% | 7,073,317 | 433.8M USD | +45.8% increased | Q3 2021 3 quarters |
| Royalty Pharma PLC | 1.7% | 10,764,472 | 419.4M USD | +4.4% increased | Q2 2020 8 quarters |
| Adaptive Biotechnologies Cor | 1.7% | 29,993,708 | 416.3M USD | unchanged | Q2 2019 12 quarters |
| Guardant Health Inc | 1.6% | 5,812,234 | 385.0M USD | +14.5% increased | Q3 2019 11 quarters |
| MRSH Marsh McLennan | 1.6% | 2,250,643 | 383.6M USD | +78.4% increased | Q4 2020 6 quarters |
| UBER Uber | 1.5% | 10,437,199 | 372.4M USD | −1.4% reduced | Q3 2021 3 quarters |
| Match Group Inc New | 1.2% | 2,744,468 | 298.4M USD | +44.5% increased | Q4 2020 6 quarters |
| Biomarin Pharmaceutical Inc | 1.2% | 3,752,393 | 289.3M USD | +30.7% increased | Q4 2021 2 quarters |
| TMO Thermo Fisher Scientific | 1.2% | 484,696 | 286.3M USD | +129.7% increased | Q2 2020 8 quarters |
| Xp Inc | 1.2% | 9,443,312 | 284.2M USD | new | Q1 2022 1 quarter |
| AMP Ameriprise Financial | 1.1% | 923,328 | 277.3M USD | −36.5% reduced | Q1 2021 5 quarters |
| OTIS Otis Worldwide | 1.1% | 3,538,164 | 272.3M USD | new | Q1 2022 1 quarter |
| Bridgebio Pharma Inc | 1.1% | 26,620,991 | 270.2M USD | unchanged | Q2 2019 12 quarters |
| META Meta Platforms | 1.1% | 1,209,602 | 269.0M USD | −35.9% reduced | Q4 2020 6 quarters |
| NOW ServiceNow | 1.0% | 440,450 | 245.3M USD | +96.4% increased | Q4 2020 6 quarters |
| Catalent Inc | 0.9% | 1,893,644 | 210.0M USD | +66.2% increased | Q1 2018 17 quarters |
| Ginkgo Bioworks Holdings Inc | 0.8% | 51,055,144 | 205.8M USD | −84.9% reduced | Q3 2021 3 quarters |
| Tenet Healthcare Corp | 0.8% | 2,233,647 | 192.0M USD | −30.4% reduced | Q1 2021 5 quarters |
| Laboratory Corp Amer HLDGS | 0.8% | 727,287 | 191.8M USD | −14.5% reduced | Q3 2020 7 quarters |
| Intellia Therapeutics Inc | 0.7% | 2,468,760 | 179.4M USD | +56.3% increased | Q2 2021 4 quarters |
| Global E Online Ltd | 0.7% | 5,128,448 | 173.2M USD | +1.8% increased | Q4 2021 2 quarters |
| DE Deere & Company | 0.7% | 403,163 | 167.5M USD | −56.8% reduced | Q1 2021 5 quarters |
| BEKE KE Holdings | 0.7% | 13,440,125 | 166.3M USD | +360.2% increased | Q4 2021 2 quarters |
| RIVN Rivian Automotive | 0.7% | 3,204,389 | 161.0M USD | unchanged | Q4 2021 2 quarters |
| Zoominfo Technologies Inc | 0.6% | 2,644,137 | 158.0M USD | −2.3% reduced | Q2 2021 4 quarters |
| LI Li Auto | 0.6% | 6,000,478 | 154.9M USD | +33.8% increased | Q4 2021 2 quarters |
| SHOP Shopify | 0.6% | 223,721 | 151.2M USD | new | Q1 2022 1 quarter |
| CRL Charles River Laboratories | 0.6% | 521,653 | 148.1M USD | +33.7% increased | Q1 2021 5 quarters |
| PODD Insulet Corporation | 0.6% | 547,387 | 145.8M USD | −19.3% reduced | Q3 2020 7 quarters |
| Acadia Healthcare Company In | 0.6% | 2,130,433 | 139.6M USD | +1.9% increased | Q4 2020 6 quarters |
| Molina Healthcare Inc | 0.6% | 416,883 | 139.1M USD | −6.9% reduced | Q3 2019 11 quarters |
| Zai Lab Ltd | 0.6% | 3,133,297 | 137.8M USD | +3.8% increased | Q1 2021 5 quarters |
| Procept Biorobotics Corp | 0.5% | 3,658,892 | 128.0M USD | −25.4% reduced | Q3 2021 3 quarters |
| BKNG Booking Holdings | 0.5% | 54,234 | 127.4M USD | −57.7% reduced | Q2 2021 4 quarters |
| Karuna Therapeutics Inc | 0.5% | 974,345 | 123.5M USD | +12.8% increased | Q3 2020 7 quarters |
| PGR Progressive Corporation | 0.5% | 1,037,306 | 118.2M USD | new | Q1 2022 1 quarter |
| Inhibrx Inc | 0.5% | 5,305,866 | 118.2M USD | unchanged | Q3 2020 7 quarters |
| Pvh Corporation | 0.5% | 1,542,375 | 118.2M USD | +100.6% increased | Q2 2020 8 quarters |
| Avantor Inc | 0.5% | 3,459,963 | 117.0M USD | −60.6% reduced | Q2 2019 12 quarters |
| Biohaven Pharmactl Hldg Co L | 0.5% | 966,139 | 114.6M USD | +177.0% increased | Q4 2021 2 quarters |
| JD JD.com (ADR) | 0.4% | 1,748,330 | 101.2M USD | −53.6% reduced | Q2 2021 4 quarters |
| Perrigo Co PLC | 0.4% | 2,525,266 | 97.0M USD | new | Q1 2022 1 quarter |
| MET MetLife | 0.4% | 1,362,166 | 95.7M USD | new | Q1 2022 1 quarter |
| Lithia Mtrs Inc | 0.4% | 316,904 | 95.1M USD | −59.9% reduced | Q1 2021 5 quarters |
| Zentalis Pharmaceuticals Inc | 0.4% | 2,026,656 | 93.5M USD | −4.3% reduced | Q2 2020 8 quarters |
| Amylyx Pharmaceuticals Inc | 0.4% | 7,170,536 | 92.1M USD | new | Q1 2022 1 quarter |
| TTWO Take-Two Interactive | 0.4% | 588,443 | 90.5M USD | −51.1% reduced | Q4 2021 2 quarters |
| DG Dollar General | 0.4% | 388,317 | 86.5M USD | new | Q1 2022 1 quarter |
| Inspire Med Sys Inc | 0.3% | 310,881 | 79.8M USD | new | Q1 2022 1 quarter |
| ELV Elevance Health | 0.3% | 140,895 | 69.2M USD | new | Q1 2022 1 quarter |
| BX Blackstone Inc. | 0.3% | 509,587 | 64.7M USD | new | Q1 2022 1 quarter |
| Celldex Therapeutics Inc New | 0.3% | 1,846,647 | 62.9M USD | +143.7% increased | Q3 2021 3 quarters |
| XYZ Block, Inc. | 0.2% | 451,534 | 61.2M USD | −0.8% reduced | Q4 2021 2 quarters |
| 4D Molecular Therapeutics In | 0.2% | 3,937,914 | 59.5M USD | unchanged | Q4 2020 6 quarters |
| BA Boeing | 0.2% | 305,347 | 58.5M USD | new | Q1 2022 1 quarter |
| Pharvaris N V | 0.2% | 2,480,319 | 46.4M USD | +1.0% increased | Q1 2021 5 quarters |
| Farfetch Ltd | 0.2% | 2,819,222 | 42.6M USD | −52.6% reduced | Q3 2021 3 quarters |
| UNH UnitedHealth Group | 0.2% | 76,910 | 39.2M USD | new | Q1 2022 1 quarter |
| Orion Acquisition Corp | 0.2% | 3,788,774 | 37.2M USD | +3.3% increased | Q1 2021 5 quarters |
| Unum Group | 0.1% | 1,137,645 | 35.8M USD | new | Q1 2022 1 quarter |
| Talaris Therapeutics Inc | 0.1% | 3,289,617 | 32.4M USD | unchanged | Q2 2021 4 quarters |
| Rallybio Corp | 0.1% | 4,194,777 | 29.3M USD | unchanged | Q3 2021 3 quarters |
| Edgewise Therapeutics Inc | 0.1% | 2,727,249 | 26.5M USD | unchanged | Q1 2021 5 quarters |
| Olaplex HLDGS Inc | 0.1% | 1,613,189 | 25.2M USD | unchanged | Q3 2021 3 quarters |
| Pmv Pharmaceuticals Inc | < 0.1% | 1,076,000 | 22.4M USD | −39.9% reduced | Q3 2020 7 quarters |
| Kinnate Biopharma Inc | < 0.1% | 1,820,462 | 20.5M USD | unchanged | Q4 2020 6 quarters |
| JPM JPMorgan Chase | < 0.1% | 119,706 | 16.3M USD | new | Q1 2022 1 quarter |
| Nuvalent Inc | < 0.1% | 1,110,170 | 15.4M USD | −32.6% reduced | Q3 2021 3 quarters |
| Day One Biopharmaceuticals I | < 0.1% | 1,157,424 | 11.5M USD | unchanged | Q2 2021 4 quarters |
| Lianbio | < 0.1% | 1,500,000 | 5.6M USD | unchanged | Q4 2021 2 quarters |
| Tdcx Inc | < 0.1% | 141,117 | 1.7M USD | −86.1% reduced | Q4 2021 2 quarters |
| Vtex | < 0.1% | 30,371 | 187.0K USD | −99.0% reduced | Q3 2021 3 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 1 position in convertible bonds and bonds worth 96.9M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Guardant Health Inc principal 120.0M USD 96.9M USD
Breakdown by sector
- Industrials 14.9%
- Financials 14.0%
- Communication Services 11.1%
- Health Care 7.8%
- Technology 7.3%
- Consumer Discretionary 6.8%
- Materials 2.0%
- Consumer Staples 0.4%
- not in our coverage 35.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors